Solid Biosciences Inc. - Common Stock $0.001 par value per share (SLDB)

CUSIP: 83422E105

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 5 signals
Share change
-11,123
SEC-reported price per share
$5.64
Number of holders
5
Value change
-$62,723
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
100,767,588

Security key

83422E105

Report period

Q4 2025

Institutions

5

Top holders

5

Ownership snapshot

Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invus Global Management, LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.6% 13D/G row: Invus Global Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Invus Global Management, LLC leads the comparable SEC ownership view at 9.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Invus Global Management, LLC's linked filing trail.
Comparable ownership Top 5
Invus Global Management, LLC 9.6%
Vestal Point Capital, LP 7.5%
Adage Capital Management, L.P. 1.8%
PERCEPTIVE ADVISORS LLC 12%
Bain Capital Life Sciences Invest... 8.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invus Global Management, LLC
13D/G
Raymond Debbane
9.6%
$27,216,371
7,415,905 shares
+$13,457,391 31 Mar 2025
Vestal Point Capital, LP
13D/G 13F
Company
7.5%
$32,796,600
5,815,000 shares
+$22,906,533 31 Dec 2025
Adage Capital Management, L.P.
3/4/5 13D/G
10%+ Owner
1.8%
from 13D/G
$32,115,515
4,248,084 shares
18 Feb 2025
PERCEPTIVE ADVISORS LLC
13F
Company
13F
12%
$73,012,936
11,833,539 shares
30 Sep 2025
Bain Capital Life Sciences Investors, LLC
13F 3/4/5
Company · 10%+ Owner
8.1%
$48,814,998
7,911,669 shares
30 Sep 2025
Siren, L.L.C.
13F
Individual
13F
7.5%
$45,756,134
7,415,905 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
5
Shares
1,370
Rows available
5
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
4
Q4 2025 holders
5
Holder diff
1
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .